Dexcom Inc (DXCM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Dexcom Inc   (NASDAQ: DXCM)
 

Dexcom Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Dexcom Inc 's inventory turnover ratio sequentially decreased to 2.81 in the second quarter 2026, unsurprisingly, as the Dexcom Inc markets continue to deteriorate, and DXCM's faces growing challenges to bring down its inventories. Dexcom Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 130 days, from 123 days, in the Mar 31 2026 quarter.

Within Healthcare sector 144 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 288.

DXCM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dexcom Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DXCM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 27.28 % 28.87 % 15.94 % 3.04 % 0.07 %
Y / Y Cost of Sales Growth 2.22 % -1.34 % 2.18 % 19.25 % 24.14 %
Inventory Turnover Ratio (TTM) 2.81 2.97 3.18 3.28 3.17
DXCM's Total Ranking # 288 # 288 # 364 # 364 # 364
Average inventory processing period 130 123 115 111 115
Seq. Inventory Growth 4.73 % 10.25 % 4.14 % 5.85 % 6.04 %
Seq. Cost of Sales Growth 8.48 % -5.77 % -1.89 % 1.92 % 4.7 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 59
Healthcare Sector # 145
Overall Market # 288

Inventory Turnover Ratio Statistics
High Average Low
7.82 4.47 2.33
(Jun 30 2013)   (Dec 31 2021)



DXCM Company Profile >> Back to DXCM Efficiency Comparisons >> Compare DXCM Inventory Turnover Ratio to its Competitors

Financial Statements
Dexcom Inc 's Inventories $ 726 Millions Visit DXCM's Balance sheet
Dexcom Inc 's Cost of Revenues TTM $ 1,864 Millions Visit DXCM's Income Statement
What are DXCM's Sales? Visit DXCM's Sales by Segment

Other Inventory Turnover Ratios
Dexcom Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DXCM's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DXCM's Competitors
Inventory Turnover Ratio for DXCM's Suppliers
Inventory Turnover Ratio for DXCM's Customers

You may also want to know
DXCM's Sales Growth Rates DXCM's Pe Price to earnings ratio DXCM's Receivables Turnover Ratio DXCM's Stock Quote
DXCM's Net Income Growth Rates DXCM's Ps Price to Sales ratio DXCM's Sales per Employee DXCM's Asset Turnover Ratio
DXCM's Net Margin DXCM's Pb Price to Book ratio DXCM's Financial Strength Ratios DXCM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Edap Tms Sa  6.05 $ 60.703  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions

Date modified: 2026-10-15T05:23:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.